AANS Beyond 2021: Scientific & Section Sessions-AANS/CNS Cerebrovascular Section

Video Transcription

Video Summary

Video 1:<br /><br />Title: Cannabis Use and Risk of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage<br /><br />Summary: This study aimed to determine if there is an association between cannabis use and delayed cerebral ischemia (DCI) in patients with aneurysmal subarachnoid hemorrhage (ASH). A retrospective study was conducted on patients admitted between 2009 and 2019. Patients were divided into cannabis users and non-users, with a total of 285 patients included. After adjusting for confounders, cannabis use was found to be independently associated with an increased risk of DCI. Further research is needed to understand the underlying mechanisms and how cessation of cannabis use may reduce the risk.<br /><br />Video 2:<br /><br />Title: Management of Small, Incidental Aneurysms without Symptoms<br /><br />Summary: For patients with small, incidental aneurysms without symptoms, conservative management with regular monitoring may be appropriate. Migraine headaches are not specifically linked to the aneurysm. Intervention with endovascular treatment or surgery should be considered based on factors such as aneurysm size, patient's overall health, and risks and benefits of intervention. Regular imaging is important for monitoring any changes in aneurysm size or shape. Patients should be educated about signs and symptoms of a ruptured aneurysm and seek immediate medical attention if they occur. Treatment decisions should be individualized based on each patient's circumstances.<br /><br />Video 3:<br /><br />Title: Innovative Treatment Approaches for Neurovascular Pathologies<br /><br />Summary: This session discussed various innovative treatment approaches for neurovascular pathologies. The first presentation focused on a biomimetic endovascular cerebrospinal fluid (CSF) shunt for communicating hydrocephalus. The second presentation discussed the use of flow diverters in treating complex aneurysms. The third presentation highlighted balloon-assisted coiling for ruptured middle cerebral artery aneurysms. The fourth presentation discussed artificial intelligence for detecting and classifying intracranial aneurysms. The final presentation focused on an endovascular device for treating subarachnoid hemorrhage through controlled infusion of therapeutic agents. These innovative approaches have potential in improving patient outcomes, but further research and development are needed.

Keywords

Cannabis use

Delayed cerebral ischemia

Aneurysmal subarachnoid hemorrhage

Retrospective study

Increased risk

Cessation of cannabis use

Management

Small, incidental aneurysms

Conservative management

Endovascular treatment

Surgery

Regular monitoring

Neurovascular pathologies

Flow diverters

Ruptured middle cerebral artery aneurysms